TickerFacts.

Aligos Therapeutics, Inc. (ALGS): Weighted Average Diluted Shares

Annual figures by period end, from SEC filings.

Stock splits: 1-for-25, first reflected in a filing dated 2024-11-06. Figures are as filed: per-share figures and share counts last reported before a split are on the old share basis, so changes and growth rates across a split are not shown. Splits are read from the filings' own restatements, so a share conversion in a merger or reorganization shows up the same way.

9.88M
Year ended 2025-12-31
42.70M2022-12-31: 42.70M2023-12-31: 2.56M2024-12-31: 6.26M2025-12-31: 9.88M9.88M
2022-12-31 Weighted Average Diluted Shares (shares) 2025-12-31

Paler bars were last filed before a stock split, on the old share basis.

Period endedWeighted Average Diluted SharesChange YoYSource filing
2025-12-319.88M+57.8%2026-03-05, From 2025-01-01
2024-12-316.26M+144.4%2026-03-05, From 2024-01-01
2023-12-312.56Mn/c2025-03-10, From 2023-01-01
2022-12-3142.70Mn/a2024-03-12, From 2022-01-01